Phreesia Osake

Phreesia EBITDA

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Phreesia (PHR) 5.8.2026 päivämäärällä on −4,16 M USD. Edellisenä vuonna EBITDA (Tulos ennen korkoja, veroja ja poistoja) oli −30,21 M USD — muutos −86,23 % (korkeampi).

EBITDA

−4,16 MUSD

YoY

−86,23%

Viimeksi päivitetty:

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Phreesia on 2026 −4,16 M USD. EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Phreesia oli 2025 −30,21 M USD. Se laskee −86,23% korkeampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Phreesia Osakeanalyysi

Mitä Phreesia tekee? Phreesia Inc is a US-based technology provider for healthcare companies that specializes in automating patient registrations and payments. The company was founded in 2005 by Chaim Indig and Evan Roberts and has since generated revenue of over $100 million. The idea for Phreesia came from Indig and Roberts' frustrating experiences in healthcare company waiting rooms, where patients were burdened with tons of paperwork to fill out. They saw the need to automate processes around patient registrations and payments, to save both patients and healthcare providers time and energy. Phreesia's business model is based on providing software and services that help healthcare companies electronically manage their patient registrations, payments, and communications. The company offers a wide range of products that include patient surveys, insurance information, consent forms, and payment processing. These products are delivered through the cloud-based Phreesia network, which healthcare companies can use to facilitate information exchange between patients and providers. Over the years, Phreesia has developed a variety of divisions, including Phreesia Pulse, Phreesia Payments, and Phreesia Patient Connect. Each of these divisions focuses on different aspects of patient registration and payments, offering specific products and services. Phreesia Pulse is one of Phreesia's key divisions and provides a platform for digital patient surveys. With this platform, healthcare companies can conduct digital surveys using tablets or other mobile devices to gather important information about the patient's medical history, symptoms, and other relevant medical data. Phreesia Payments is another important division of Phreesia, offering a payment processing solution. By integrating payment processing into patient registration and communication, patients can make their payments directly through Phreesia, and healthcare providers can automatically send payment reminders via email or SMS. Phreesia Patient Connect is an innovation that allows patients to connect with their doctor through Phreesia's patient portal. Through the portal, patients can view their medical information, schedule appointments, and communicate with their doctor. Overall, Phreesia has experienced remarkable growth and success in the healthcare market. The company has received numerous awards, including the "Best in KLAS" award in the Patient Access category, as well as being named the "Fastest Growing Company in the Triad" by the Triad Business Journal. Phreesia's business model has fundamentally changed and improved the way healthcare companies manage their patient administration and payments. Not only does Phreesia provide its customers with the necessary tools to automate the registration and payment information of their patients, but it also enables a higher level of patient satisfaction by enhancing information exchange and interaction through digital platforms. As a leading healthcare technology provider, Phreesia will continue to stay true to its mission of developing innovative tools and services that improve the way healthcare companies care for their patients. Phreesia on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Phreesia osakkeesta

Yhtiön Phreesia EBITDA (Tulos ennen korkoja, veroja ja poistoja) on −4,16 M USD vuonna 2026.

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Phreesia muuttui arvosta −30,21 M USD arvoon −4,16 M USD, mikä edustaa −86,23 % muutosta. Arvo on korkeampi kuin edellisenä vuonna.

Eurpoolissa voit löytää EBITDA (Tulos ennen korkoja, veroja ja poistoja) Phreesia:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

EBITDA mittaa operatiivista suorituskykyä ennen rahoitusrakenteen, veroympäristön ja muiden kuin käteispoisto-osuuksien vaikutusta.

EBITDA = EBIT + Poistot

EBITDA (Tulos ennen korkoja, veroja ja poistoja):n USD on sijoittajille tärkeä tekijä. Muutokset tässä tunnusluvussa voivat signaloida parantuvia tai heikentyneitä perustekijöitä, mikä vaikuttaa suoraan osakekurssiin. Eulerpoolissa voit seurata EBITDA (Tulos ennen korkoja, veroja ja poistoja):n Phreesia historiallisesti ja reaaliajassa.

Access this data via the Eulerpool API

Tuloslaskelma — Phreesia

Kaikki tunnusluvut — Phreesia